These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16672188)

  • 1. Licensing of monovalent OPV1 vaccine.
    Farag MM
    Biologicals; 2006 Jun; 34(2):145-9. PubMed ID: 16672188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manufacturing and supply of monovalent oral polio vaccines.
    Graf H
    Biologicals; 2006 Jun; 34(2):141-4. PubMed ID: 16682217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monovalent polio immunisation--a strategy for India.
    Chatterjee A; Chawla A
    J Indian Med Assoc; 2005 Dec; 103(12):682-5. PubMed ID: 16821665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress toward poliomyelitis eradication--India, January 2007-May 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Jul; 58(26):719-23. PubMed ID: 19590492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.
    Băicuş A; Persu A; Combiescu M; Aubert-Combiescu A
    Roum Arch Microbiol Immunol; 2007; 66(1-2):44-50. PubMed ID: 18928063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A vision of a world without polio: the OPV cessation strategy.
    Heymann DL; Sutter RW; Aylward RB
    Biologicals; 2006 Jun; 34(2):75-9. PubMed ID: 16682224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OPV cannot eradicate polio from India: do we need any further evidence?
    Paul Y
    Vaccine; 2008 Apr; 26(17):2058-61. PubMed ID: 18378367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of monovalent oral polio vaccine mutagenesis in vaccinated elderly people.
    Boot HJ; Sonsma J; van Nunen F; Abbink F; Kimman TG; Buisman AM
    Vaccine; 2007 Jun; 25(24):4706-14. PubMed ID: 17482726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of oral polio vaccine for polio eradication.
    Bhatnagar P; Bahl S; Biswal P
    J Indian Med Assoc; 2005 Dec; 103(12):680-1. PubMed ID: 16821664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India.
    Grassly NC; Jafari H; Bahl S; Durrani S; Wenger J; Sutter RW; Aylward RB
    J Infect Dis; 2009 Sep; 200(5):794-801. PubMed ID: 19624278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress toward poliomyelitis eradication--India, January 2006-September 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Nov; 56(45):1187-91. PubMed ID: 18004237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress toward poliomyelitis eradication--Nigeria, 2005-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(12):278-81. PubMed ID: 17392680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polio eradication in India: current status.
    Bahl S; Biswal P; Sarkar S; Jenks J; Petersen T; Wenger J
    J Indian Med Assoc; 2005 Dec; 103(12):669-70, 678. PubMed ID: 16821660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress toward poliomyelitis eradication--Nigeria, January 2007-August 12, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Aug; 57(34):942-6. PubMed ID: 18756194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. World wide experience with inactivated poliovirus vaccine.
    Bonnet MC; Dutta A
    Vaccine; 2008 Sep; 26(39):4978-83. PubMed ID: 18680777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of mutations in the VP(1) region of Sabin strain type 1 polioviruses isolated from vaccine-associated paralytic poliomyelitis cases in Iran.
    Rahimi P; Tabatabaie H; Gouya MM; Zahraie M; Mahmudi M; Ziaie A; Rad KS; Shahmahmudi Sh; Musavi T; Azad TM; Nategh R
    J Clin Virol; 2007 Aug; 39(4):304-7. PubMed ID: 17590391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of alternative polio immunization policies in South Africa.
    Griffiths UK; Botham L; Schoub BD
    Vaccine; 2006 Jul; 24(29-30):5670-8. PubMed ID: 16766096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral poliovirus vaccine type 3 from a patient with transverse myelitis is neurovirulent in a transgenic mouse model.
    Thorley B; Kelly H; Nishimura Y; Yoon YK; Brussen KA; Roberts J; Shimizu H
    J Clin Virol; 2009 Apr; 44(4):268-71. PubMed ID: 19269246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress toward interruption of wild poliovirus transmission--worldwide, January 2007-April 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 May; 57(18):489-94. PubMed ID: 18463607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.